128 related articles for article (PubMed ID: 32527129)
1. Glans metastatic extra-nodal natural killer/T-cell lymphoma, nasal-type with HDAC inhibitor as maintenance therapy: a rare case report with literature review.
Fu C; Yang C; Li Q; Wang L; Zou L
Ann Palliat Med; 2020 Sep; 9(5):3602-3608. PubMed ID: 32527129
[TBL] [Abstract][Full Text] [Related]
2. Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report.
Xu J; Xu X; Chen J; Wang J; Jiang C; Lv C; Chen B
Medicine (Baltimore); 2021 Mar; 100(10):e24824. PubMed ID: 33725836
[TBL] [Abstract][Full Text] [Related]
3. Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement: a case report and review of the literature.
Wang X; Gong Z; Li SX; Yan W; Song Y
BMC Urol; 2017 Sep; 17(1):77. PubMed ID: 28874193
[TBL] [Abstract][Full Text] [Related]
4. [Incidence and treatment of extranodal natural killer/T-cell lymphoma nasal type. Hungarian experiences].
Bakos A; Szomor Á; Schneider T; Miltényi Z; Marton I; Borbényi Z; Pammer J; Krenács L; Bagdi E; Piukovics K
Orv Hetil; 2017 Oct; 158(41):1635-1641. PubMed ID: 29025287
[TBL] [Abstract][Full Text] [Related]
5. [Extra-nodal NK/T-cell lymphoma, nasal-type, revealed by cutaneous and ocular involvement].
Marzouki-Zerouali A; Charbit L; Mitcov M; Violon F; Schmutz JL; Moawad S; Bursztejn AC
Ann Dermatol Venereol; 2019 Oct; 146(10):626-633. PubMed ID: 31371036
[TBL] [Abstract][Full Text] [Related]
6. Establishment and comprehensive analysis of a new human cell line (NK-NJ) with NK-cell characteristics established from extranodal natural killer cell lymphoma/leukemia.
Liang JH; Wang WT; Du KX; Xing TY; Wang Y; Wang H; Liu L; Guo R; Shao Y; Liang J; Li Y; Shen HR; Wang L; Li JY; Xu W
Hum Cell; 2023 Mar; 36(2):835-846. PubMed ID: 36520345
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological study of pulmonary extranodal nature killer/T-cell lymphoma, nasal type and literature review.
Ding W; Wang J; Zhao S; Yang Q; Sun H; Yan J; Gao L; Yao W; Zhang W; Liu W
Pathol Res Pract; 2015 Jul; 211(7):544-9. PubMed ID: 25953340
[TBL] [Abstract][Full Text] [Related]
8. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
[TBL] [Abstract][Full Text] [Related]
9. Combination of atezolizumab and chidamide to maintain long-term remission in refractory metastatic extranodal natural killer/T-cell lymphoma: A case report.
Wang J; Gao YS; Xu K; Li XD
World J Clin Cases; 2022 Feb; 10(5):1609-1616. PubMed ID: 35211600
[TBL] [Abstract][Full Text] [Related]
10. A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type.
Xu PP; Xiong J; Cheng S; Zhao X; Wang CF; Cai G; Zhong HJ; Huang HY; Chen JY; Zhao WL
EBioMedicine; 2017 Nov; 25():41-49. PubMed ID: 29056540
[TBL] [Abstract][Full Text] [Related]
11. Up-front autologous hematopoietic stem cell transplantation after first complete remission improved prognosis of advanced extra-nodal NKT cell lymphoma: A multicenter real-world study in China.
Gao H; Lin N; Gu Z; Zhao S; Wang X; Yuan S; Song Y; Zhu J; Huang W; Liu W; Gao C
Eur J Haematol; 2023 Jun; 110(6):680-687. PubMed ID: 36825748
[TBL] [Abstract][Full Text] [Related]
12. Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type.
Dobashi A; Tsuyama N; Asaka R; Togashi Y; Ueda K; Sakata S; Baba S; Sakamoto K; Hatake K; Takeuchi K
Genes Chromosomes Cancer; 2016 May; 55(5):460-71. PubMed ID: 26773734
[TBL] [Abstract][Full Text] [Related]
13. Clinical study of l-asparaginase in the treatment of extranodal NK/T-cell lymphoma, nasal type.
Yong W
Hematol Oncol; 2016 Jun; 34(2):61-8. PubMed ID: 25899032
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase (HDAC) inhibitors when combined with a proteasome inhibitor are safe and effective in patients with extranodal natural killer/T-cell lymphoma (ENKTL).
Tan D; Diong CP; Loh Y; Goh YT
Ann Oncol; 2016 Sep; 27(9):1811-2. PubMed ID: 27287208
[No Abstract] [Full Text] [Related]
15. Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.
Shi Y; Dong M; Hong X; Zhang W; Feng J; Zhu J; Yu L; Ke X; Huang H; Shen Z; Fan Y; Li W; Zhao X; Qi J; Huang H; Zhou D; Ning Z; Lu X
Ann Oncol; 2015 Aug; 26(8):1766-71. PubMed ID: 26105599
[TBL] [Abstract][Full Text] [Related]
16. Extra-Nodal, Nasal, Natural Killer T-Cell Lymphoma Treated With a Checkpoint Inhibitor: A Case Report of a Sustained Complete Response.
Diab R; Kamran S; Adcock B; Choucair K; Truong QV
Cureus; 2021 Apr; 13(4):e14654. PubMed ID: 34046285
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutation.
Tsuyama N; Asaka R; Dobashi A; Baba S; Mishima Y; Ueda K; Oguchi M; Tsuji H; Hatake K; Takeuchi K
Hematol Oncol; 2018 Feb; 36(1):328-335. PubMed ID: 28695659
[TBL] [Abstract][Full Text] [Related]
18. SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal natural killer/T-cell lymphoma, nasal type.
Wei L; Wang L; Cong J; Yang L; Ye J; Li X; Yao N; Yang J; Wang J
Leuk Res; 2020 Sep; 96():106422. PubMed ID: 32721642
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin.
Kim SJ; Kim JH; Ki CS; Ko YH; Kim JS; Kim WS
Ann Oncol; 2016 Mar; 27(3):508-13. PubMed ID: 26658891
[TBL] [Abstract][Full Text] [Related]
20. Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.
Vazquez A; Khan MN; Blake DM; Sanghvi S; Baredes S; Eloy JA
Laryngoscope; 2014 Apr; 124(4):888-95. PubMed ID: 24114591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
